[O1] Oral 1 ART-1

9:00 〜 9:09

[O1-1] Peripheral blood mononuclear cell therapy demonstrates significantly improved outcomes for challenging IVF patient groups in global clinical data

^○Yevheniia Zhylkova^1,2,3, Oleksandr Feskov^{1 2}, Stanislav Zhilkov^{1 3}, Kamden Burke¹ (1.Department of Laboratories, Cell Therapy Holdings LLC, 2.Department of Laboratories, IVF center of prof. Feskov, 3.Product Development, AB Fertility Inc)

閲覧にはパスワードが必要です